These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36683539)

  • 1. Type 4 renal tubular acidosis and uric acid nephrolithiasis: two faces of the same coin?
    Adomako EA; Maalouf NM
    Curr Opin Nephrol Hypertens; 2023 Mar; 32(2):145-152. PubMed ID: 36683539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uric acid stone disease: lessons from recent human physiologic studies.
    Tran TVM; Maalouf NM
    Curr Opin Nephrol Hypertens; 2020 Jul; 29(4):407-413. PubMed ID: 32398609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal ammonium excretion after an acute acid load: blunted response in uric acid stone formers but not in patients with type 2 diabetes.
    Bobulescu IA; Maalouf NM; Capolongo G; Adams-Huet B; Rosenthal TR; Moe OW; Sakhaee K
    Am J Physiol Renal Physiol; 2013 Nov; 305(10):F1498-503. PubMed ID: 24026180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal tubular acidosis in recurrent renal stone formers.
    Mateos Antón F; García Puig J; Gaspar G; Martínez ME; Ramos T; Martínez Piñeiro JA
    Eur Urol; 1984; 10(1):55-9. PubMed ID: 6698089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The syndrome of distal (type 1) renal tubular acidosis. Clinical and laboratory findings in 58 cases.
    Caruana RJ; Buckalew VM
    Medicine (Baltimore); 1988 Mar; 67(2):84-99. PubMed ID: 3127650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased production and reduced urinary buffering of acid in uric acid stone formers is ameliorated by pioglitazone.
    Maalouf NM; Poindexter JR; Adams-Huet B; Moe OW; Sakhaee K
    Kidney Int; 2019 May; 95(5):1262-1268. PubMed ID: 30795852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic syndrome and uric acid nephrolithiasis.
    Sakhaee K; Maalouf NM
    Semin Nephrol; 2008 Mar; 28(2):174-80. PubMed ID: 18359398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal stone risk factors in patients with type IV renal tubular acidosis.
    Uribarri J; Oh MS; Pak CY
    Am J Kidney Dis; 1994 Jun; 23(6):784-7. PubMed ID: 8203358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance.
    Abate N; Chandalia M; Cabo-Chan AV; Moe OW; Sakhaee K
    Kidney Int; 2004 Feb; 65(2):386-92. PubMed ID: 14717908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of recurrent stone formers with special reference to renal tubular acidosis.
    Singh PP; Pendse AK; Ahmed A; Ramavataram DV; Rajpurohit SK
    Urol Res; 1995; 23(3):201-3. PubMed ID: 7483148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology and clinical pathophysiology of uric acid kidney stones.
    Sakhaee K
    J Nephrol; 2014 Jun; 27(3):241-5. PubMed ID: 24497296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening renal stone formers for distal renal tubular acidosis.
    Osther PJ; Hansen AB; Røhl HF
    Br J Urol; 1989 Jun; 63(6):581-3. PubMed ID: 2752250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incomplete Distal Renal Tubular Acidosis and Kidney Stones.
    Fuster DG; Moe OW
    Adv Chronic Kidney Dis; 2018 Jul; 25(4):366-374. PubMed ID: 30139463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Might distal renal tubular acidosis be a proximal tubular cell disorder?
    Donnelly S; Kamel KS; Vasuvattakul S; Narins RG; Halperin ML
    Am J Kidney Dis; 1992 Mar; 19(3):272-81. PubMed ID: 1553972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperkalemic Forms of Renal Tubular Acidosis: Clinical and Pathophysiological Aspects.
    Batlle D; Arruda J
    Adv Chronic Kidney Dis; 2018 Jul; 25(4):321-333. PubMed ID: 30139459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Type IV renal tubular acidosis: pathogenetic role of aldosterone deficiency and hyperkalemia].
    Schambelan M; Sebastian A
    Nephrologie; 1985; 6(3):135-7. PubMed ID: 3908957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beware the low urine pH--the major cause of the increased prevalence of nephrolithiasis in the patient with type 2 diabetes.
    Bell DS
    Diabetes Obes Metab; 2012 Apr; 14(4):299-303. PubMed ID: 21992452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fasting versus 24-h urine pH in the evaluation of nephrolithiasis.
    Capolongo G; Sakhaee K; Pak CY; Maalouf NM
    Urol Res; 2011 Oct; 39(5):367-72. PubMed ID: 21336574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephrolithiasis in renal tubular acidosis.
    Buckalew VM
    J Urol; 1989 Mar; 141(3 Pt 2):731-7. PubMed ID: 2645431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urine composition in type 2 diabetes: predisposition to uric acid nephrolithiasis.
    Cameron MA; Maalouf NM; Adams-Huet B; Moe OW; Sakhaee K
    J Am Soc Nephrol; 2006 May; 17(5):1422-8. PubMed ID: 16597681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.